 |
[Alpha Biz=(Chicago) Reporter Paul Lee] Celltrion fell 4% on the first day of its merger with Celltrion Healthcare. It is analyzed that the stock price has been diluted as 74 million shares have been newly released into the market.
According to the Korea Exchange on the 15th, Celltrion closed at 196,900 won, down 3.95% on the same day. It is the first time that Celltrion's stock price has broken by 200,000 won since Dec. 27 last year (189,000 won).
Experts say Celltrion Healthcare's shares merged with Celltrion changed to 73,887,750 common shares of Celltrion, weakening its stock price in the aftermath of its further listing.
Earlier, Celltrion and Celltrion Healthcare held a shareholders' meeting on October 23 last year and approved the merger of the two companies. The merger value per share between the two companies was KRW 148,853 for Celltrion and KRW 66,874 for Celltrion Healthcare, with 0.4492620 shares of Celltrion common stock allocated per share of Celltrion Healthcare.
AlphaBIZ 폴 리(hoondork1977@alphabiz.co.kr)
